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Introduction   
This fourteenth annual update of the HIV/AIDS 
literature on Ethiopia includes references to studies 
covering all major public health aspects of this 
infection in Ethiopia and in Ethiopians in the diaspora. 
All references are again listed under eight main 
headings, as follows: 1) basic biomedical research, 2) 
epidemiological, behavioral socioeconomic and 
cultural research, 3) impacts research, 4) treatment, 
care and clinical research, 5) prevention research, 6) 
health services and policy research, 7) health 
informatics and evaluation research and 8) research on 
Ethiopians in the diaspora. The text preceding each list 
of references briefly summarizes patterns, trends, and 
major findings of studies, and attempts to highlight 
some of the new approaches, concepts and tools used 
and reported in 2016. As in previous updates, we used 
a simple categorization approach where a citation 
appears only in one section. In reality, complex studies 
cover multiple topics and areas. Thus, we continue to 
encourage readers interested in any one area of 
research to review also other sections in this update. 
Overall, we hope that this annual update will, like 
previous issues, serve as a resource for researchers 
interested in HIV/AIDS epidemiology, prevention, 
control, care and support in Ethiopia and among 
Ethiopians in the diaspora. 
 
We used the same methods as in previous updates to 
identify and classify references. Literature searches 
using keywords “Ethiopia AND HIV AND 2016” and 
“Ethiopia AND AIDS AND 2016” were made in 
PubMed, CINHAL, EconLit, EMBASE, Global 
Health, POPLINE, PsycINFO, Social Services 
Abstracts, Sociological Abstracts, and other major 
databases that archive relevant published articles, 
dissertation, and reports from multiple sources. We 
made additional online searches on major national and 
regional HIV/AIDS resource centers and international 
organizations, mostly http://www.etharc.org and 
http://unaids.org.  
 
There are 436 references in this update – 32 references 
fewer than the previous update. More than half (243 or 
55.7%) of the references are published articles; 147 
(33.7%) are conference abstracts, 45 (10.3%) are 
thesis, and 1 (0.2%) is a report. All of thesis were from 
Addis Ababa University. It was not possible to access 
theses from Jimma, Gondar, Hawassa, Mekele, or other 
universities as in some of the previous updates.  
 
Trends in International AIDS Conference 
Presentations: We continued to monitor trends in 
conference presentations at the biannual International 
AIDS Conference (IAC) by searching for abstracts 
containing “Ethiopia” in the International AIDS 
Society’s abstract archive (http://www.abstract-
archive.org/). The years and conference locations were: 
1st (Atlanta, 1985), 2nd (Paris, 1986), 3rd (Washington, 
1987), 4th (Stockholm, 1988), 5th (Montreal, 1989), 6th 
(San Francisco, 1990), 7th (Florence, 1991), 8th 
(Amsterdam, 1992), 9th (Berlin, 1993), 10th 
(Yokohama, 1994), 11th (Vancouver, 1996), 12th 
(Geneva, 1998), 13th (Durban, 2000), 14th (Barcelona, 
2002), 15th (Bangkok, 2004), 16th (Toronto, 2006), 17th 
(Mexico City, 2008), 18th (Vienna, 2010), 19th 
(Washington, 2012), 20th (Melbourne, 2014), 21st 
(Durban, 2016). As Figure 1, Panel A shows, 
conference presentations at the IAC increased linearly 
from 1985 to 2006 – with the highest number of 
presentations at 137 in Toronto in 2006. Since then, 
there has been a declining trend in IAC presentations 
presumably because of visa issues, travel expenses, or 
availability of other conference opportunities in 
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Figure 1: Presentations at the International Conference on AIDS (A) and Publications cited in PubMed (B) 
concerning Ethiopia and HIV or AIDS, 1985-2016. 
 
Trends in Published Studies Archived in PubMed: 
As the largest database of abstracts of scientific 
publications, PubMed provides an opportunity to 
monitor the trends in publication of HIV/AIDS related 
studies. We searched for published studies archived in 
PubMed database using the following terms: Ethiopia 
AND HIV [dp] or Ethiopia AND AIDS [dp].  Covering 
the years 1985 through 2016.  Figure 1, Panel B, 
presents the number of unique articles archived in 
PubMed for each year. There appears an increasing 
trend in published articles starting from 2006 and it has 
continued through 2016. While this trend may be tied 
to increasing number of online journals being archived 
in PubMed, it is also likely because of increased 
productivity of researchers. Similarly, Figure 2 
presents trends in publications of articles on other 
common infections, including tuberculosis (TB) and 
malaria. Unlike previous updates, which included 
publication trends on schistosomiasis (until 2012), this 
update includes publication trends in helminth 
infections because of the growing relevance of parasitic 
infections in health outcomes of people living with 
HIV/AIDS in Ethiopia (see Section 2). For Figure 2, 
the Pub Med search terms were: Ethiopia AND HIV 
[dp]; Ethiopia AND AIDS [dp]; Ethiopia AND malaria 
[dp]; Ethiopia AND tuberculosis [dp]; Ethiopia AND 
helminth [dp]. These searches were further stratified by 
year of publication (2007-2016). The results show 
increasing trends in publications citing HIV, AIDS, 
tuberculosis, and malaria, but a stabilizing or declining 















































































































































































































































































































278     Ethiop. J. Health Dev. 
 
Ethiop. J. Health Dev. 2017;31(4) 
 
Figure 2: Publications Cited in PubMed Concerning Ethiopia and HIV, AIDS, Tuberculosis, Malaria, and 
Helminths, 2007-2016 
 
Section 1: Basic Biomedical Research  
This section covers laboratory-based biomedical 
research, including studies on HIV structure, 
replication, and host immune responses; co-infection 
with other agents; development and testing of 
laboratory procedures; and other related laboratory 
studies. 
 
In 2016, there are 32 references classified as 
Biomedical Research, up from only 11 in 2015. There 
are 19 references on different aspects of tuberculosis 
including 5 published papers, 5 theses, and 9 
conference presentations. There are 3 papers, 2 theses, 
and 1 conference presentation focused on HIV. The 
remaining 7 references, including 4 papers, concerned 
various opportunistic infections and diseases that may 
be exacerbated in the context of HIV infection and 
immunodeficiency. 
 
Derbie et al. (11) evaluated the relatively new, PCR-
based Xpert-MTB/RIF assay for the detection of M. 
tuberculosis and drug-resistant TB in nearly 2,000 
presumptive TB patients in Bahir Dar and Debre 
Tabor. The authors concluded that the test resulted in 
more accurate diagnoses of TB and multi drug-resistant 
(MDR) TB and would avoid inappropriate treatment of 
patients who actually do not have TB. The system is 
rapid and particularly suitable in places where bacterial 
culture facilities are not available. These findings were 
also presented at the Ethiopian Public Health 
Association (EPHA) Conference (10). TB diagnostics 
was also the topic of a presentation by Deriba et al. 
(12) at the EPHA meeting comparing cultural methods 
– the relatively new mycobacterial growth indicator 
tube (MGIT) system that gives time-to-positivity 
results with the classical Lowenstein-Jensen culture 
method that yields colonies of Mtb – at the national 
reference laboratory in Addis Ababa. In a presentation 
at the Ethiopian Medical Association (EMA) Fantahun 
et al. (15) compared cultural and molecular methods 
for the diagnosis of tuberculous lymphadenopathy at 
St. Paul’s Hospital in Addis Ababa. A thesis by A. 
Gadissa (16) evaluated still another TB diagnostic 
technique, LED fluorescent microscopy, compared 
with Xpert at Ambo Hospital. At the EMA, Cherinet et 
al. (8) also evaluated LED fluorescent microscopy and 
the issue of stain fading. At the EPHA, Gebretsadik et 
al. (17) assessed the phenotypic and genotypic 
characteristics of Mtb isolates and their drug 
susceptibility in Debre Berhan. A thesis by S. 
Getachew (18) assessed Mtb isolates from 
lymphadenopathy patients by spoligotyping. A thesis 
by A. Meaza (23) along with a conference presentation 
by Meaza et al. (24) assessed another molecular assay, 
MTBDRplus, for TB diagnosis. A thesis (27) and 
EPHA presentation (28) by B. Sherefedin evaluated the 
use of the Xpert test in clinics in Addis Ababa. Tilahun 
et al. (29) presented their finding concerning Mtb 
molecular epidemiology and drug susceptibility in 
Ambo at the EPHA meeting. Also at the EPHA 
meeting, Zewdie et al. (32) presented their findings on 
the molecular epidemiology of Mtb isolates from 
lymphadenitis patients in Addis Ababa. A thesis by D. 
Addise (1) addressed the issue of decontamination of 
sputum samples with sodium hydroxide and its impact 
on the detection of mycobacteria and contaminating 
microbes. A paper by Awoniyi et al. (6) assessed 
production of multiple cytokines in response to novel 
Mtb antigens and their utility for TB diagnosis. 
Overall, it was encouraging to note the range of assays 
and settings in Ethiopia being evaluated for TB 
diagnosis in this year’s papers, theses, and conference 
abstracts. The availability of and appropriate use of 
these assays should increase the diagnostic accuracy, 
specificity, and sensitivity for the control of TB. 
 
In other TB-related research, a paper by Habtewold et 
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TB drug, rifampicin (RIF), administered together with 
the anti-HIV drug, efavirenz (EFV). They found no 
significant influence of RIF-based anti-TB co-therapy 
on the EFV pharmacokinetic exposure measures but 
cautioned that the regimen and high EFV metabolite 
levels could increase the risk of neurotoxicity in female 
patients with the CYP2B6*6 genotype. By exploring 
host gene expression in HIV+ patients with active and 
latent TB, Kassa et al. (21) identified increased 
expression of the chemokine CCL22 and 
immunoglobulin receptor, FCGR1A, in particular, and 
to a lesser extent, three other genes, as having potential 
to discriminate with active from latent TB. In another 
paper, Kassa et al. (20) also reported that the 
production of certain cytokine/chemokine markers in 
response to Mtb antigens in whole blood assays might 
also help discriminate active and latent TB in HIV-
infected patients and also monitor patient responses to 
anti-HIV and TB treatment. 
 
Using a variety of genetic tests to characterize the HIV-
1 subtype C that predominates in Ethiopia, Amogne et 
al. (4) found that the HIV-1 C strains from Ethiopia, 
obtained in 2008, are more similar than those from 
other regions and that the distinctions are more 
detectable at near full-length than sub-genomic 
assessments. Drug resistance mutations were at low 
levels. Aralaguppe et al. (5) demonstrated the 
feasibility of a simple sequencing approach that can 
potentially be used in the molecular surveillance of 
HIV-1 for effective identification of subtypes and 
transmission clusters for operational public health 
intervention. Kobeb and Degu (22) showed that CD4 
levels increase over the first 18 months in children in 
response to antiretroviral treatment and that the benefit 
is greater if HAART is initiated at higher CD4 levels. 
At the EPHA Conference, Mulu (26) reported that a 
10-year study showed that HIV-1C strains retain 
homogeneity in spite of increasing trends of drug 
resistance. A thesis by E. Woldu (30) showed the 
importance of time and temperature on absolute CD4 
counts. Using a rat model, the thesis by A. 
Wondimnew (31) explored the effects of a leaf extract 
on HAART-induced dyslipidemia and non-alcoholic 
fatty liver disease. 
 
By reviewing the literature on antifungal drug 
resistance patterns in sub-Saharan Africa, Africa and 
Abrantes (2) concluded that there is a need for a 
revision of antifungal therapy guidelines with better 
controls in antimicrobial drug distribution and 
implementation of antimicrobial surveillance programs 
to reduce the high Candida drug resistance levels 
emerging the region. Moges et al. (25) found 31% 
resistance to six antifungal agents against 
oropharyngeal candidiasis (OPC) in HIV-infected 
patients in Addis Ababa, highlighting the need for 
study on the epidemiology of OPC and resistance to 
antifungal drugs. Alebachew et al. (3) found that 
bacterial sepsis was a major cause of admission for 
HIV infected patients in Gondar, predominantly 
Staphylococcus aureus and coagulase negative 
staphylococci species. Most of the isolates were 
multidrug resistant. 
 
Diro et al. (13) showed that the sensitivity and 
specificity of buffy coat and peripheral blood 
mononuclear cell smear microscopy could be relatively 
high and much safer than tissue (e.g., spleen) biopsy in 
HIV co-infected visceral leishmaniasis patients. At the 
EPHA, Demeke et al. (9) reported on the 
immunogenicity of Leishmania-derived antigens in 
treated visceral leishmaniasis patients from southwest 
Ethiopia. 
 
At the EMA Conference, Eshetu et al. (14) evaluated 
the burden and genotype distribution of high-risk 
human papilloma virus types and cytology 
abnormalities found in selected obstetric and 
gynecologic clinics in Addis Ababa. Birhanu et al. (7) 
reported to the EPHA the association of disease 
severity, hemozoin-containing leukocytes and 
hematological parameters in children with malaria in 
northwest Ethiopia. They excluded HIV-infected 
patients from the study. 
 
Addise D. Effect of 1.5% sodium hydroxide final 
concentration for the detection of mycobacterium 
species and identification of bacterial and fungal 
contamination at Ethiopian Public Health Institute, 
Addis Ababa, Ethiopia.  Thesis, Addis Ababa 
University; 2016. 
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Section 2: Epidemiological, Behavioral, Socio-
Economic and Cultural Research 
This section includes studies on the epidemiology of 
HIV and other opportunistic infections, AIDS and 
related diseases, and risk and protective behaviors. It 
also covers research on the biological, psychosocial, 
socioeconomic, cultural, structural, and other 
contextual determinants of HIV transmission and 
prevention. 
 
This section contains 138 references: 72 (52.2%) 
published articles, 55 (39.8%) conference abstracts, 
and 11 (8.0%) masters theses. As in previous years, the 
broad categories of research interest within this section 
included: 1) prevalence and determinants of HIV 
infection; 2) prevalence and associated factors of 
opportunistic infections and other comorbidities; 3) 
HIV risk perceptions and risk behaviors; 4) HIV-
related social norms and practices; 5) other existing 
research areas.  An interesting focus area in this update 
is the epidemiology of cervical cancer. 
 
HIV Prevalence and Determinants:  While no major 
national surveys on HIV prevalence were reported in 
2016, researchers continued to monitor the prevalence 
of HIV among samples of individuals, including 
among those who donate blood, receive services at 
emergency health departments or participate in 
voluntary HIV testing and counseling programs. In a 
retrospective review of the records of 2,606 blood 
donors screened at Gambo Rural Hospital in Western 
Arsi, HIV prevalence was found to be 0.7% (100). In 
another similar retrospective study involving analysis 
of 5 years of medical records (2009 to 2013) of blood 
donors at the blood bank of Yirgalem Hospital in 
Hawassa, HIV infection was found among 1.6% of 
6367 donors (36). Abate et al. (1) reviewed the records 
of 6,827 blood donors aged 17-65 years in Jigjiga and 
found HIV positivity to be 3.16%. Three other studies 
found higher prevalence rates in samples from 
emergency departments or voluntary testing and 
counseling programs. In retrospective study that 
examined the prevalence of HIV and other infectious 
diseases among specimen samples left from 797 
individuals who attended Tikur Anbessa Hospital in 
Addis Ababa, HIV infection was 11.2% (79). Sinku et 
al. (115) examined HIV prevalence and the associated 
factors among 2,120 voluntary counseling and testing 
(VCT) clients at the University of Gondar Teaching 
Hospital. The authors found that 17.1% of the sample 
to be seropositive for HIV. Shiferaw et al. (110) 
conducted a review of records of all new patients who 
were screened at a voluntary HIV testing and 
counseling center in Kombolcha town from February 8, 
2005 to December 31, 2014. The authors found an 
overall HIV infection rate of 10.8%. The authors noted 
that the rate of infection declined significantly from 
13.3% in 2005 to 4.5% in 2014. 
  
The above and other studies (66, 67, 107) have 
documented increased vulnerability of some population 
groups because of their personal attributes, their 
position in society, or their geographical placement. 
For example, in a qualitative study that explored the 
social determinants of HIV infection, Kaba et al. (66, 
67) found daily laborers, female sex workers, students 
who are living away from family, widows, separated 
and divorced women, those who work in restaurants 
and engaged in petty trade were found to be relatively 
more vulnerable population groups. While the 
variability of the prevalence estimates reflects the 
differences in the characteristics of the samples 
(general population vs. patient population; small vs. 
large town), they all suggest that HIV is still a major 
public health problem in Ethiopia despite positive 
national trends reported in previous updates. Continued 
monitoring of HIV prevalence, and when possible HIV 
incidence, would be important to monitor progress 
towards national HIV prevention goals and to inform 
public health programs. 
 
Early diagnosis of HIV infection is critical to disrupt 
further transmission of HIV by providing an 
opportunity for reductions in risk behaviors and entry 
into treatment and subsequent viral suppression. Aniley 
et al. (20) studied factors associated with delayed 
diagnosis of HIV infection among a sample of 392 
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HIV-diagnosed persons, half of whom had a delayed 
diagnosis and the other half who were controls without 
delayed diagnosis. The researchers found having no 
understanding about HIV and ART, being tested for 
presence of symptoms/illness, and acquiring HIV 
through sexual contact were independent and 
significant factors associated with late HIV diagnosis – 
pointing the need for programs to raise awareness 
about the benefits of HIV testing and the effectiveness 
of antiretroviral therapies. 
 
Overall, these highlighted studies underscore the need 
for continued research on the patterns and trends of 
HIV prevalence in the country with a focus on the most 
vulnerable groups of the population in order to design 
better HIV prevention, treatment, and care programs. 
  
HIV and Opportunistic Infections: As in previous 
updates, a plurality of studies has examined the 
prevalence, determinants, or outcomes of co-infections 
of HIV and tuberculosis, including studies on 
tuberculosis among PLWH (13, 14, 15, 88), HIV 
among TB suspected cases (50), TB and HIV co-
infection among prisoners (53), tuberculosis among 
PLWH on ART (55), and social determinants and 
delayed presentation among tuberculosis and HIV co-
infected patients (59, 60). It is important to note that 
HIV and tuberculosis co-infections remain to be high, 
as shown by 27.7% tuberculosis infection among a 
sample of adult HIV patients in Amhara region (88) 
and roughly similar proportions (20-30%) of 
tuberculosis patients who were diagnosed with an HIV 
co-infection (50, 53). This level of co-infection should 
be seen within the broader context of tuberculosis 
infection among various population groups, which 
several studies in this update covered (7, 8, 30, 55, 76, 
97, 105, 106, 133, 137), including studies on the 
prevalence, determinants, and impacts of multi-drug 
resistant tuberculosis (9, 34, 44, 86). 
 
Several studies focus on the epidemiology of hepatitis 
virus infections in different population groups (blood 
donors, patients visiting emergency departments, VCT, 
antenatal care, or ART clinics, prisoners, and the 
general population). The most commonly studied 
hepatitis virus infections were infections with hepatitis 
B (HBV; 33, 36, 61, 69, 80, 84, 95, 100, 138) and 
hepatitis C (HCV; 1, 25, 33, 79, 80, 100, 103, 138), 
although infections with other hepatitis viruses, 
including hepatitis A (HAV; 33), hepatitis D (HDV; 
33) or hepatitis E (HEV; 4, 33) have also been 
reported. The systematic review and meta-analytic 
study by Belyhun and colleagues (33) provides a 
summary and a good start to understand the magnitude, 
geographic and population distribution of hepatitis 
virus infections in Ethiopia. In this study, the authors 
conducted a systematic review of 68 studies and a 
meta-analysis of 55 studies to summarize viral hepatitis 
epidemiology and the potential clinical burdens in 
Ethiopia.  Overall pooled prevalence estimates were 
7.4% for HBV and 2.4% for HCV. The authors 
acknowledged that although there are relatively few 
studies on hepatitis virus HAV, HDV, and HEV, all 
types of viral hepatitis virus infections are endemic in 
Ethiopia and suggested adapting routine screening and 
treatment for hepatitis infections in healthcare systems 
and implementing prevention and control policies in 
the general population. 
 
Researchers were also interested in prevalence of and 
risk factors for infections with other sexually 
transmitted disease, particularly syphilis, among HIV-
negative and/or HIV-positive persons (1, 16; 32, 36, 
39, 69).  The 10-year trend data reported by Kassa et 
al. (69) showed a continuous decrease in syphilis in 
both HIV positive and negative pregnant women (from 
2.5% to 1.1%) in Kombolcha, although prevalence 
rates of syphilis remained higher among HIV-positive 
women than those who were HIV-negative. There has 
also been continued interest in prevalence, risk factors, 
and impacts of intestinal parasites among people living 
with HIV/AIDS (49, 115, 120, 136) and other 
population groups (65).  These studies find high levels 
of intestinal parasites among PLWHA and the general 
public, and lead to the recommendation that public 
health agencies expand routine screening, treatment, 
and prevention services for parasitic infections. Other 
infectious disease studied included malaria (5, 46), 
herpes (11), meningitis (74) and schistosomiasis (127). 
Further research on the interaction of these disease 
with HIV will be important to design treatment 
programs and improve the health outcomes of 
PLWHA. 
 
HIV and Other Co-morbidities: In Ethiopia and other 
developing countries, the relationships between 
nutrition and HIV infection are complex. On one hand, 
poverty and food insecurity are closely tied to 
vulnerability to HIV infection and poor health 
outcomes. On the other, HIV disease and its treatment 
regimens contributes to nutritional disorders. Thus, 
researchers are interested in exploring the prevalence 
of malnutrition and nutritional deficiencies among the 
general population or among PLWHA (3, 12, 35, 49, 
52, 58, 87, 94, 120). Mitiku et al. (87) and colleagues 
found undernutrition in 23.2% of a sample of HIV 
positive adults attending ART clinic in Dembia 
District. In another study, Mulu et al. (94) found 
indicators of malnutrition among 44-49% of 
HIV/AIDS patients attending Jimma University 
Specialized Hospital. Both studies found several 
factors to be associated with nutritional deficiencies, 
including CD4 count less than 200 cells/mL.  These 
studies underscored the importance of addressing both 
nutritional deficiencies and HIV disease among 
PLWHA. One unique co-morbidity studied was the 
prevalence of common mental disorders among HIV-
positive adolescents in Addis Ababa (64). Behavioral 
health issues, including substance abuse and mental 
health, are neglected areas and thus further researched 
would be highly valuable. 
 
HIV Risk Perceptions and Risk Behaviors:  As in 
previous updates, several studies have also reported on 
HIV/AIDS related knowledge, perceptions, and risk 
behaviors among young people, mostly in academic 
settings (10, 21, 42, 45, 70, 71, 82, 96, 101, 108)  but 
also in other settings (37, 75, 117, 123). These studies 
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continue to document low levels of risk perception and 
high levels of sexual risk behaviors, including earlier 
sexual initiation, premarital sex, unprotected sex, sex 
with multiple partners, and sex with commercial sex 
workers. In addition, some these studies have also 
identified substance use behaviors that are associated 
with sexual risk behaviors, including khat chewing, 
consumption of alcohol, and use of illicit drugs. Most 
of these studies tend to be small, cross-sectional and 
limited to specific geographical locations, and should 
be treated as supplements to national level behavioral 
risk factors surveys that are crucial for monitoring 
trends in HIV-related knowledge, perception, and risk 
behaviors. Studies with other priority population 
groups, including commercial sex workers, out-of-
school youth, men who have sex with other men, and 
persons who use drugs are still needed. 
     
HIV-Related Social Norms and Practices: The role 
of prevailing social norms and practices that are 
detrimental to HIV infection were investigated in 
studies that examined the prevalence of and associated 
factors for gender-based or intimate partner violence 
and harassment against women, including pregnant 
women (2), married women (41, 92, 93), female 
federal police (72), women working in government 
institutions (41), and female university students (123). 
Manning-Geist et al.  (81) conducted a retrospective 
analysis of the medical outcomes of 1,712 survivors of 
rape seen in two clinics in Adama and Hawassa. The 
researchers found that 13.3% of patients tested positive 
for a sexually transmitted infection (gonorrhea, 
hepatitis B, syphilis, or HIV), 9.0% were pregnant, 
16.8% had genital injury, and 4.7% had evidence of 
other body trauma. Although most of these studies are 
conference presentations and their abstracts were 
unavailable for a review, they demonstrate continued 
interest in this topic and further help increase 
awareness and inform future research or interventions 
towards changing negative social norms.  Three 
additional studies focused on another aspect of gender-
based violence against girls and women – female 
genital mutilation or cutting (FGM; 19, 26, 68, 98). 
The research by Andualem (19) examined the 
prevalence and determinants of FGM among 730 
women aged 15-49 years and their < 5 year old 
daughters.  The study found out that 96% of the 
mothers and 49% of their daughters had experienced 
FGM. The likelihood of FGM among daughters was 
higher among parents with lower levels of education, 
those who resided in rural areas, and those who had a 
maternal history of FGM. In contrast, FGM was less 
likely among those who received health education, 
followed by health extension workers, and those who 
participated in anti-FGM interventions. These findings 
are encouraging because they hint that FGM may be 
declining and that health education and anti-FGM 
interventions can help reverse this negative social 
practice. Other social norms and practices studied 
include masculine norms that contribute to men’s HIV-
related risk behaviors (51), gender norms and family 
planning decisions among married men and women 
(56); marginality and social mobility among HIV-
positive women (104); and infant oral mutilation and 
risk for infections (63). Further research on these social 
determinants of HIV infection will help advance social 
and structural interventions against HIV/AIDS. 
 
Cervical Cancer Epidemiology: A higher than 
previously reported number of studies have focused on 
cervical cancer (23, 29, 47, 91, 111, 112, 113).  In a 
conference abstract, Assefa (23) reported that 35.9 new 
cases of cervical cancer are diagnosed and 22.6 die 
from it per 100,000 women annually in Ethiopia. In a 
review of the patterns of genital cancer investigated at 
St Paul Hospital Millenium Medical College 
(SPHMMC) Ethiopian Public Health Institute (EPHI) 
pathology laboratory, the authors found that 30.6% of 
the 13,043 pathological tumors diagnosed at the 
hospital were cervical cancers (47). Four other studies 
examined knowledge and perceptions about cervical 
cancer among female students (91), among HIV-
positive women (, 111, 112, 113).  Shiferaw et al. (111, 
112) found that knowledge about cervical cancer was 
generally low and concluded that awareness programs 
should be strengthened at both community and health 
facility levels with emphasis highlighting the causes, 
risk factors, care seeking behaviors, and treatment 
options for cervical cancer. In one of those studies, 
barriers to cervical cancer screening among HIV 
positive women in Addis Ababa were explored (113). 
Given the availability of vaccines that would help 
prevent most cervical cancers, research on 
epidemiology and knowledge and perceptions of 
cervical cancer would be valuable for informing future 
public health policy and practice. 
 
Other Existing HIV/AIDS Research Topics: There 
were also studies that reported on other topics covered 
previous updates. Three studies reported research on 
healthcare related practices that might contribute to 
HIV acquisition or transmission among healthcare staff 
or patients, including one study on the incidence and 
patterns of surgical glove perforations (31) and two 
other studies on prevalence and risk factors for needle 
stick injury among healthcare workers (109, 129). 
Other studies explored issues including knowledge, 
attitudes, and practice related to mother-to-child 
transmission of HIV among pregnant women (6), 
determinants of fertility desires among PLWHA (90), 
infant feeding practices among HIV-positive women 
(125, 135), broader reproductive and sexual health 
needs among young people with disability (73), 
prisoners (39), and South Sudanese immigrants in 
Ethiopia (124).   
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Section 3: Impact Research 
This section covers studies of the demographic, social, 
psychological, and economic impacts of HIV/AIDS on 
individuals, families, communities, institutions and the 
nation. 
 
This section includes 24 references to impact studies, 7 
more than in the 2015 Update. Eleven of the studies 
dealt with mortality and survival from AIDS and TB 
(1-4, 6-8,14,16,19), mental health and quality of life 
(15,20,21,24), socioeconomic impacts (12,17,23), HIV 
and TB impacts on disease burden and other diseases 
(9,11,13,18,22), and the impact of HIV stigma on ART 
clients (10) and suicide (5). 
 
Most studies of health impacts emphasized the need to 
diagnose health conditions and initiate appropriate 
counseling and treatment activities early to reduce 
morbidity and mortality levels (5,9,14,16,19,22) and 
reported on mortality and survival of patients with 
ART/TB coinfections (1,2,4,11,14,16) and on mental 
health impacts of HIV and AIDS (5,15,20,21,24). 
 
A national burden of disease and injuries study using 
Global Burden of Disease data from 2013 (4) and 
various statistical estimation methods and age 
standardized data showed reduction of HIV/AIDS by 
63% and of tuberculosis by 66% between 2005 and 
2013. Contrary to these results, a longitudinal 
community-based study, using the verbal autopsy 
method reported that mortality from tuberculosis 
consistently increased during the six-year study period 
(2). Gebremariam et al. (11), in a 6-year retrospective 
study, found that TB patients who did not know their 
HIV status were significantly more likely to default 
and transfer out of treatment. These findings 
reemphasize the need for integrated HIV/TB testing at 
treatment initiation. 
  
Five studies addressed mental health challenges faced 
by HIV/AIDS patients, an increasingly important issue 
in the ART era.  Tesfaye et al. (21) found a strong link 
between food insecurity, mental health and quality of 
life. Vo et al. (24) reported significant higher overall 
function and life satisfaction scores than men. Whereas 
Surur (15) found no significant association between 
illness conditions and quality of life in a HIV/AIDS 
patient population in generally good health, Tesfaw et 
al. (20) reported a strong link between HIV stage III 
and depression and anxiety. Both studies identified 
different independent factors that were significantly 
associated with quality of life. Bitew et al. (5) reported 
that one-third of people living with HIV contemplated 
and 20% attempted suicide and called for early 
screening, treatment and referral of suicidal patients. 
 
Three studies addressed socioeconomic impacts of HIV 
on the livelihoods of individuals and interventions at 
the community level. Tsiko (23) addressed the issue of 
access to land by HIV-infected women. He found that 
both urban and rural women had more access to own 
land than to acquire family land, indicating stigma and 
social ostracism against HIV-positive women. The 
impacts of HIV infection on socioeconomic conditions 
infected people reported by Hailu (12) were also 
reported by earlier studies. A sociological study of five 
Ethiopian NGOs engaged in strengthening of 
livelihoods in communities affected by HIV/AIDS 
reported suboptimal results of their programs due to 
deficient design, implementation, monitoring and 
evaluation of the interventions, which resulted in 
inadequate interactions between the NGOs and the 
communities (17). 
  
One study reported on the impact of HIV stigma on 
treatment outcome. Fido et al. (10) found significant 
associations between duration of ART use and all three 
types of stigma (experienced, internalized, and 
perceived stigma), again emphasizing the need for 
early HIV counseling of new ART patients. 
 
One of the first studies in Ethiopia of the association 
between undernutrition with increased risk of death at 
the initiation of ART indicates the need to integrate 
nutrition counseling at all stages of ART 
implementation to improve treatment outcome (19). 
Several maternal and pediatric studies addressed 
various issues related to HIV. Assefa et al. (3) found 
formula-fed infants to have four times lower risk of 
HIV infection than breast-fed infants and called for 
stepped up efforts to provide ARV for HIV-positive 
mothers to reduce the risk of mother-to-child 
transmission. However, there is a need to conduct 
additional studies in rural areas, where safe bottle 
feeding may be compromised by unsafe water, as 
reported in earlier studies. Bohn et al. (6) reported the 
highest mortality rates from all causes, including 
HIV/AIDS, early during hospitalization in a hospital in 
Addis Ababa. Deribew et a. (8), using various data 
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sources, found that mortality from all causes in 
Ethiopia in under 5-year olds declined from 20.05 per 
100,000 to 16.67/100,000 between 1990 and 2013.  
We are advising readers to visit other sections, which 
contains additional references to studies reporting on 
HIV linked mortality, morbidity, and other socio-
economic impacts on patients, their families, 
communities, and the nation. 
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following antiretroviral clinic at Jimma University 
specialized hospital, southwest Ethiopia. Global 
Heart 2016;1:e26. 
19. Tesfamariam K, Baraki N, Kedir H. Pre-ART 
nutritional status and its association with mortality 
in adult patients enrolled on ART at Fiche Hospital 
in North Shoa, Oromia Region, Ethiopia: a 
retrospective cohort study. BMC Res Notes 
2016;9(1):512. 
20. Tesfaw G, Ayano G, Awoke T, Assefa D, Birhanu 
Z, et al. Prevalence and correlates of depression 
and anxiety among patients with HIV on-follow up 
at Alert Hospital, Addis Ababa, Ethiopia. BMC 
Psychiatry 2016;16(1):368. 
21. Tesfaye M, Kaestel P, Olsen MF, Girma T, Yilma 
D, et al. Food insecurity, mental health and quality 
of life among people living with HIV commencing 
antiretroviral treatment in Ethiopia: a cross-
sectional study. Health Qual Life Outcomes 
2016;14:37. 
22. Tsegaw M, Andargie G, Alem G, Tareke M. 
Screening HIV-associated neurocognitive 
disorders (hand) among HIV- positive patients 
attending antiretroviral therapy in South Wollo, 
Ethiopia. J Psychiatr Res 2017;85:37-41. 
23. Tsiko RG. Geographically weighted regression of 
determinants affecting women's access to land in 
Africa. Geosciences (2076-3263) 2016;6(1):1-26. 
24. Vo QT, Hoffman S, Nash D, El-Sadr WM, 
Tymejczyk OA, et al. Gender differences and 
psychosocial factors associated with quality of life 
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among ART initiators in Oromia, Ethiopia. AIDS 
Behav 2016;20(8):1682-1691. 
 
Section 4: Prevention Research  
This section includes reports on research and 
programmatic activities that aimed at provision of 
prevention services targeted at HIV/AIDS and related 
opportunistic infections. Information and behavioral 
change communication, provision of voluntary testing 
and counseling and prevention of mother-to-child 
transmission, community mobilization, and other risk-
reduction efforts against HIV/AIDS are studies 
included in this section. 
 
This section summarizes 51 papers that focus on HIV 
prevention that were published, presented at 
conferences or produced for partial fulfillment of 
Masters of Public Health training during 2016. Updates 
in this section are classified as theses (12), papers 
presented at national as well as international 
conferences (19) and published articles in peer 
reviewed journals (20). All the papers were outcomes 
of cross sectional studies except one (34), a 
randomized control trial. This control trial looked into 
the persistent educational activities and its implication 
on HIV testing. 
 
The papers in this section were categorized into  sexual 
behavior including contraceptives, reproductive and 
condom (12), social and behavioral change 
communication and knowledge, attitudes and practices 
as relates to HIV and AIDS (10), male/partner 
involvement in HIV intervention including in PMTCT 
(5), cervical cancer and HIV focusing on single  visit 
services (4) adherence to treatment (3), VCT (2) and 
others (single references on TB-HIV, breast feeding, 
PICT, and lost to follow-up). 
 
The sexual behavior including contraceptives (1, 3, 6, 
20, 22, 28, 33, 40, 41, 43, 48 and 50) highlighted 
various areas related to condom, family planning and 
other contraceptive service use among those who live 
with the virus. The second set of references was on 
social behavioral change communication including 
knowledge, attitude and practices related to HIV and 
AIDS (3,11,13,15,16,17,18, 30, 37 and 49). Papers in 
this category mainly addressed behavior change 
strategies/approaches, interventions and impacts, 
predictors of behavior change. In this section, one 
paper took behavior change communication and KAP 
to providers where communications and language use 
in a medical setting was addressed (16). 
 
Male/partner involvement (4, 27, 35, 46 and 51) is 
another category in this section that focuses on role of 
male/partner in PMTCT and VCT service use and 
partner notification. One of the papers in this category 
assessed progress, impact and next steps in rolling out 
medical male circumcision for HIV prevention in 14 
priority countries of Eastern and Southern Africa. This 
is believed to shade light on prevailing practices on 
medical male circumcision and next steps. 
 
In this update a new area of research output on single 
visit service for cervical cancer and HIV testing (7, 25, 
32 and 44) was recorded. Lessons drawn from 
prevention of cervical cancer, screening experiences   
and documentation of years of the single visit approach 
to cervical cancer were the major focus. Three papers 
on levels of adherence and predictors were recorded in 
this section (9, 10, 47). 
 
Unlike previous years’, research interest in voluntary 
counseling and testing, TB-HIV co-infection, breast 
feeding and PICT was limited during this year. There 
were only 2 papers (14,45) that focused on factors 
affecting VCT uptake, two papers on TB-HIV co-
infection (8,21) one focusing on the practice of TB 
contact screening and childhood isoniazid preventive 
therapy while another one documented the evolution of 
Mycobacterium TB and implication for vaccine 
development. One paper each was found on predictors 
of exclusive breastfeeding (5) and predictors of 
provider -initiated HIV counseling and testing refusal 
among out-patients (19). 
 
1. Abebe A. Assessment of consistent and correct 
condom use among commercial sex workers 
(CSWs) in Addis Ababa, Ethiopia: a case control 
study comparing CSWs on intervention and out of 
intervention.  Thesis, Addis Ababa University; 
2016. 
2.  Abiye A. A study of the social and behavioral 
change communication strategies of Ethiopia to 
prevent HIV/AIDS.  Thesis, Addis Ababa 
University; 2016. 
3. Alemu T. Modern contraceptive use by female 
ART attendants in Arada sub-city, Addis Ababa, 
Ethiopia: A cross sectional study.  Thesis, Addis 
Ababa University: 2016. 
4. Amano A, Musa A. Male involvement in PMTCT 
and associated factors among men whom their 
wives had ANC visit 12 months prior to the study 
in Gondar Town, north west Ethiopia, December, 
2014. Pan Afr Med J 2016;24:239. 
5. Arage G, Gedamu H. Exclusive breast feeding 
practice and its associated factors among mothers 
of infants less than six month of age in Debre 
Tabor Town, northwest Ethiopia: a cross sectional 
study. Paper presented at the 27th Annual 
Conference of the Ethiopian Public Health 
Association; Addis Ababa; 2016, Abstract no. 
Poster 15. 
6. Asimamaw B. The role of peers in influencing 
adolescents’ sexual behavior in the case of Beshale 
secondary and preparatory school.  Thesis, Addis 
Ababa University; 2016. 
7. Asnake M, Kassahun K, Shiferaw N, Belayihun B. 
"Addis tesfa" (new hope) project's lesson on the 
prevention of cervical cancer in Ethiopia. Paper 
presented at the 27th Annual Conference of the 
Ethiopian Public Health Association; Addis 
Ababa; 2016, Abstract no. 103. 
8. Assefa B. The practice of TB contact screening 
and childhood isoniazid preventive therapy (IPT) 
in Addis Ababa.  Thesis, Addis Ababa University; 
2016. 
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9. Ayele HT, Mourik MSV, Bonten M. Predictors of 
adherence to isoniazid preventive therapy in HIV 
patients in Ethiopia: a prospective cohort study. 
Paper presented at the 17th International Congress 
on Infectious Diseases; Hyderabad, India; 2016, 
Abstract no. 43.089.  
10. Ayele HT, van Mourik MS, Bonten MJ. Predictors 
of adherence to isoniazid preventive therapy in 
people living with HIV in Ethiopia. Int J Tuberc 
Lung Dis 2016;20(10):1342-1347. 
11. Bekalu MA, Eggermont S, Viswanath KV. 
HIV/AIDS communication inequalities and 
associated cognitive and affective outcomes: a call 
for a socioecological approach to AIDS 
communication in Sub-Saharan Africa. Health 
Commun 2017;32(6):685-694. 
12. Bezabih T, Menbere M-S. Participation in 
economic strengthening (ES) intervention and 
health related quality of life (HRQOL) among 
food insecure people living with HIV (PLHIV) in 
Ethiopia. Paper presented at the 21st International 
AIDS Conference; Durban, South Africa; 2016, 
Abstract no. TUPED350. 
13. Biock G, Miligo B, Saha A, Sellers T. Peer to peer 
learning on preventing anti-homosexuality bills: 
the DR Congo and Burkina Faso case study. Paper 
presented at the 21st International AIDS 
Conference; Durban, South Africa; 2016, Abstract 
no. TUPED412. 
14. Bizuayehu HM. Voluntary HIV counseling and 
testing services utilization among pregnant women 
in northwest Ethiopia in 2014. Paper presented at 
the 27th Annual Conference of the Ethiopian 
Public Health Association; Addis Ababa; 2016, 
Abstract no. 9. 
15. Degefa N. Assessment of knowledge, attitude, and 
preventive practices towards sexually transmitted 
infections among Arsi Negelle Kiture preparatory 
school students, West Arsi Zone, Oromia, 
Ethiopia, 2016. Thesis, Addis Ababa University; 
2016. 
16. Desalegn A. “A stich in time saves nine”: TB, 
communication and language in medical settings 
in Harari Region.  Thesis, Addis Ababa 
University; 2016. 
17. Ebrahim NB, Davis S, Tomaka J. Attitude as a 
mediator between acculturation and behavioral 
intention. Public Health Nurs 2016;33(6):558-564. 
18. Evangeli M, Pady K, Wroe AL. Which 
psychological factors are related to HIV testing? a 
quantitative systematic review of global studies. 
AIDS Behav 2016;20(4):880-918. 
19. Facha W, Kassahun W, Workicho A. Predictors of 
provider-initiated HIV testing and counseling 
refusal by outpatient department clients in Wolaita 
Zone, southern Ethiopia: a case control study. 
BMC Public Health 2016;16:783. 
20. Fetene N. Assessment of the effect of youth 
centers on reduction of risky sexual behaviors 
among youth in Addis Ababa, 2016. Thesis, Addis 
Ababa University; 2016. 
21. Gagneux S. Evolution of Mycobacterium 
tuberculosis and implications for vaccine 
development. Ethiop Med J 2016;54(2):95-100. 
22. Gelaw B. Assessment of magnitude and factors 
affecting intention of women living with HIV to 
use long-acting and permanent family planning 
methods in Addis Ababa City government public 
health hospitals, Addis Ababa, Ethiopia. Paper 
presented at the 27th Annual Conference of the 
Ethiopian Public Health Association; Addis 
Ababa; 2016, Abstract no. 13. 
23. Geletu ZA, Kowalski M, Tesfaye A, Umer S. 
Reaching key populations in urban settings 
through home-based HIV testing and counseling 
by urban health extension professionals in 
Ethiopia. Paper presented at the 21st International 
AIDS Conference; Durban, South Africa; 2016, 
Abstract no. THPEE516. 
24. Genetu H, Yenit MK, Tariku A. Breastfeeding 
counseling and support are associated with 
continuous exclusive breastfeeding from one week 
to six months of age among HIV exposed infants 
in North Gondar Zone, Ethiopia: a cross-sectional 
study. Int Breastfeed J 2016;12:21. 
25. Getachew E. Knowledge, attitudes and practices 
on cervical cancer and screening among 
reproductive health service clients, Addis Ababa, 
Ethiopia, 2015. Paper presented at the 27th Annual 
Conference of the Ethiopian Public Health 
Association; Addis Ababa; 2016, Abstract no. 12. 
26. Girma A. Assessment of PMTCT and ART 
services in Hawassa Health Centre, Ethiopia.  
Paper presented at the American Public Health 
Association's 2016 Annual Meeting and Expo; 
Denver, CO, USA; 2016, Abstract no. Board 4. 
27. Harling G, Barnighausen T. The role of partners' 
educational attainment in the association between 
HIV and education amongst women in seven sub-
saharan african countries. J Int AIDS Soc 
2016;19(1):20038. 
28. Hawulte B, Degefa B. Family planning use among 
women seeking abortion care in Harar health 
facilities, Harar Town, eastern Ethiopia. Paper 
presented at the 27th Annual Conference of the 
Ethiopian Public Health Association; Addis 
Ababa; 2016. 
29. Imana G, Hamza L, Woldemichael K. Isonizid 
preventive therapy utilization rate and associated 
factors in adult HIV/AIDS patients in Jimma 
University Specialized Hospital ART clinic: a 
cross-sectional study. Paper presented at the 52nd 
Annual Medical Conference of the Ethiopian 
Medical Association; Addis Ababa; 2016, Abstract 
no. P013. 
30. Jani N, Vu L, Kay L, Habtamu K, Kalibala S. 
Reducing HIV-related risk and mental health 
problems through a client-centered psychosocial 
intervention for vulnerable adolescents in Addis 
Ababa, Ethiopia. J Int AIDS Soc 2016;19(5 Suppl 
4):20832. 
31. Kassahun K, Asnake M, Shiferaw N. The role of 
community support groups in strengthening 
cervical cancer prevention services in Ethiopia. 
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Paper presented at the 27th Annual Conference of 
the Ethiopian Public Health Association; Addis 
Ababa; 2016, Abstract no. Poster 6. 
32. Kassahun K, Shiferaw N, Tilahun Y, Lew C, 
Osakwe C, et al. From pilot to national scale up: 
the legacy of pathfinder international-Ethiopia’s 
single visit approach for cervical cancer prevention 
among HIV-positive women. Paper presented at 
the 21st International AIDS Conference; Durban, 
South Africa; 2016, Abstract no. WEPEE533. 
33. Ketema A. Assessment of effects of exposure to 
sexually explicit materials on early sexual 
initiation and other risky sexual behavior. Thesis, 
Addis Ababa University; 2016. 
34. Kim HB, Haile B, Lee T. Promotion and 
persistence of HIV testing and HIV/AIDS 
knowledge: Evidence from a randomized 
controlled trial in Ethiopia. Health Econ 
2017;26(11):1394-1411. 
35. Kripke K, Njeuhmeli E, Samuelson J, Schnure M, 
Dalal S, et al. Assessing progress, impact, and next 
steps in rolling out voluntary medical male 
circumcision for HIV prevention in 14 priority 
countries in eastern and southern Africa through 
2014. PLoS One 2016;11(7):e0158767. 
36. Mark D, Ngombe A, Burford G, Renaud N, 
Djoumessi V, et al. Project reach: a facility-based 
peer support model across 20 facilities in five Sub-
Saharan African countries. Paper presented at the 
21st International AIDS Conference; Durban, 
South Africa; 2016, Abstract no. TUPEB126. 
37. Mekonnen S. Analysis of HIV/AIDS prevention 
messages communicated to university students: 
message framing in focus. Thesis, Addis Ababa 
University; 2016. 
38. Mitiku I, Arefayne M, Mesfin Y, Gizaw M. 
Factors associated with loss to follow-up among 
women in option B+ PMTCT programme in 
northeast Ethiopia: a retrospective cohort study. J 
Int AIDS Soc 2016;19(1):20662. 
39. Negash TG, Ehlers VJ. An assessment of the 
outcomes of prevention of mother-to-child 
transmission of HIV services in Addis Ababa, 
Ethiopia. Curationis 2016;39(1):1583. 
40. Negash W, Dessalegn M, Yitayew B, Demsie M, 
Wagnew M, et al. Reproductive health service 
utilization and associated factors: the case of North 
Shewa Zone youth, Amhara Region, Ethiopia. Pan 
Afr Med J 2016;25(Suppl 2):3. 
41. Nigussie TS. Factors affecting contraceptive use 
among women of reproductive age group in Surma 
Woreda, southwestern Ethiopia: cross-sectional 
community based study.  Paper presented at the 
52nd Annual Medical Conference of the Ethiopian 
Medical Association; Addis Ababa; 2016, Abstract 
no. P022. 
42. Samuel M. Determinants of condom use among 
Addis Ababa university students: The case of 
students in the main campus. Thesis, Addis Ababa 
University; 2016. 
43. Shiferaw N, Salvador-Davila G, Kassahun K, 
Brooks MI, Weldegebreal T. The single-visit 
approach as a cervical cancer prevention strategy 
among women with HIV in Ethiopia: successes 
and lessons learned. Global Health: Science and 
Practice 2016;4(1):87-98. 
44. Teklehaimanot HD, Teklehaimanot A, Yohannes 
M, Biratu D. Factors influencing the uptake of 
voluntary HIV counseling and testing in rural 
Ethiopia: a cross sectional study. BMC Public 
Health 2016;16(239):1-13. 
45. Tsadik M. Partner notification for sexually 
transmitted infections is an overlooked strategy in 
Ethiopia Paper presented at the National STD 
Prevention Conference; Atlanta, GA, USA; 2016, 
Abstract no. WP6. 
46. Tsegaye D, Deribe L, Wodajo S. Levels of 
adherence and factors associated with adherence to 
option B+ prevention of mother-to-child 
transmission among pregnant and lactating 
mothers in selected government health facilities of 
South Wollo Zone, Amhara Region, northeast 
Ethiopia, 2016. Epidemiol Health 
2016;38:e2016043. 
47. Van Renterghem H, Benedikt C, Deperthes B, 
Dallabetta G, Broxton C, et al. Estimating condom 
needs and gaps for fast-tracking people-centred 
condom programming in Sub-Saharan Africa. 
Paper presented at the 21st International AIDS 
Conference; Durban, South Africa; 2016, Abstract 
no. LBPE025. 
48. Yilma S. Assessment of knowledge, attitude, and 
intention to use long acting and permanent 
contraceptive methods among women in HIV 
chronic care. Thesis, Addis Ababa University; 
2016. 
49. Zemenu S, Tizta T, Mulusew G. Contraceptive 
discontinuation and patterns of method switching 
among women of reproductive age in Jimma 
Town, southwest Ethiopia. Paper presented at the 
27th Annual Conference of the Ethiopian Public 
Health Association; Addis Ababa; 2016, Abstract 
no. Poster 76. 
50. Zenebe A, Gebeyehu A, Derseh L, Ahmed KY. 
Male partner's involvement in HIV counselling 
and testing and associated factors among partners 
of pregnant women in Gondar Town, northwest 
Ethiopia. J Pregnancy 2016;2016:3073908. 
 
Section 5: Treatment, Care and Clinical Research 
This section includes studies in the characteristics and 
clinical course of HIV infection and opportunistic 
infections, treatment of AIDS and opportunistic 
infections, effects and outcomes associated with 
treatment, clinical and non-clinical care and supportive 
services provided to people living with HIV/AIDS.  
 
This section includes studies on the characteristics and 
clinical course of HIV infection and opportunistic 
infections, treatment for HIV infection and 
opportunistic infections, effects and outcomes 
associated with treatment, and clinical and non-clinical 
care and supportive services provided for people living 
with HIV/AIDS. 
 
This section contains 103 references in this category, 
35 fewer than in the 2015 update. Sixty-one are 
published documents, all except 1 of them journal 
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articles, 33 are conference abstracts and   the remaining 
9 are masters theses. The most common research topics 
in this Update are treatment outcome (30 references), 
adherence to treatment, attrition and loss to follow-up 
(21 references), and clinical and antiretroviral drug 
evaluation studies (3, 23, 26,29, 30, 45, 65, 70, 73, 76, 
80, 94, 98). 
 
Most studies of treatment outcome dealt with treatment 
of HIV/TB and HIV/hepatitis B coinfections (5, 15, 31, 
36, 74, 98, 100), TB treatment (3, 12, 13, 28, 53, 62, 
82, 83, 102, 103), ART failure (14, 27, 35, 66, 88),  
ART treatment (24, 42, 54, 55), chronic care of HIV-
infected persons (1, 41, 44, 90, 96,97), including one 
study on client satisfaction (97) and one on 
accessibility of HIV/AIDS treatment (96), which are 
two understudied issues, and causes and outcomes of 
the timing of initiating drug therapy (16, 36, 63, 92). 
Three studies reported on the difficulties of treating 
visceral leishmaniasis (49, 76, 798) and one study on 
the impact of visceral leishmaniasis treatment on poor 
treatment outcome in HIV patients (4). 
 
This Update presents additional studies of the role of 
different aspect of nutrition status and food 
supplementation in the treatment process, including the 
impact of therapeutic food on ART outcome and 
patient retention (20, 39), the impact of HAART on 
nutritional and immunological status in HIV-infected 
children (23), on vitamin D levels (99) and 
anthropometric parameters (78). Other studies 
investigated the role of ART on hematological 
abnormalities (29), anemia (61), metabolic syndrome 
(38), atherosclerosis (34), hepatitis B genome 
variability (1), renal and liver function (94,98), pre-
term births (60) and quality of life (68). 
 
Several studies measured the progression of ART in 
patients. Three studies modeled CD4 counts in HIV-
positive individuals on ART (33, 72, 75). Wondafrash 
et al. (93) evaluated the dried blood spot test in testing 
the viral treatment status of HIV-exposed children. 
Kalibala et al. (41) evaluated several algorithms for 
HIV care and treatment. A global study of research on 
scaling up access to HIV viral load testing for patients 
receiving ART emphasized the crucial need for early 
ART initiation through universal access and equity of 
viral load testing for HIV treatment monitoring to meet 
the UN Program on HIV/AIDS 90-90-90 goals by 2020 
(69). Mamuye et al. (48) recommended the use of 
fingerstick whole blood samples of HIV patients for 
on-site diagnosis of cryptococcal meningitis. 
 
The nine maternal and pediatric studies in this section 
are in line with an increase of these studies since the 
2013 Update.  Two studies each examined adherence 
of children to ART (8,21) and chronic care of HIV-
exposed and sick children (36,44). Additional studies 
reported on testing children on ART to monitor their 
treatment status ((93), the effect of ART on the clinical 
interventions (40), ART adherence of pregnant and 
lactating mothers in a PMTCT program (89), the 
association between protease inhibitor based ART 
during pregnancy and pre-term birth (6) and a study of 
outcome of tympanoplasty, which showed higher 
treatment failure among HIV-infected children (40). 
 
One study reported no significant differences in 
treatment outcomes between new HIV patients in 
primary health care facilities and hospitals (51). These 
results contradict the widely held belief that hospitals 
provide better treatment for HIV-infected persons but 
additional studies are required to validate these 
findings. 
 
Most studies of the continuum and interruption of ART 
and TB drug treatment focused on 
adherence/discontinuation and its associated factors 
(8,17,21,25,32,47,50,52,56,64,85,87,89,90) and the 
relationship between adherence and treatment outcome 
(16,18,20, 28, 69,74). One study examined adherence 
to isoniazid preventive therapy by AIDS patients (15). 
 
A number of studies addressed perceptions about ART 
and TB treatment delays and methods to increase and 
monitor adherence. Tymejczyk et al. (90) found that 
few adults initiating ART believed that if can prevent 
sexual transmission of HIV and many thought that holy 
water (tsebel) could cure AIDS. Erku et al. found 
stigma to cause interruption of ART adherence (25). 
Tiruneh et al. (85) attributed daily irregularities in 
adherence to dose schedules to patients’ perception and 
beliefs. Tola et al. (87) found that psychological and 
educational interventions guided by the Health Belief 
Model significantly reduced non-adherence to TB 
treatment, indicating the usefulness of behavioral 
theories in routine treatment strategy. Wondiye et al. 
(95), using the grounded theory approach, examined a 
wide range of barriers to ART, including individual, 
medical, environmental and economic factors. These 
various results have potential application for behavioral 
interventions addressing non-adherence to ART, which 
continues to be high in Ethiopia and many other 
countries. Salla Munro et al., in a review of health 
behavior theories to promote long-term medication 
adherence for TB and HIV/AIDS, BMC Public Health, 
2007, examined 11 theories and called for urgent 
research and analysis to identify the models which may 
be most effective in improving adherence to treatment 
regimens for chronic infectious diseases. 
 
Several studies evaluated recently developed methods 
to monitor and facilitate ART adherence. Platt et al. 
(71) found multiplex cathepsin zymography to be a 
reliable and low-cost electrophoresis-based assay for 
monitoring ART adherence in resource limited settings. 
Mekuria et al. (56-58) used mixed methods to identify 
the most reliable adherence measure. Two studies 
reported on the acceptability of using text messages to 
send medication reminders to patients on ART (43) and 
on the effectiveness of ART adherence supporters in 
re-enlisting patients lost to care (79). Biru et al. (24) 
advocated large-scale studies using a combination of 
adherence measuring methods to more precisely define 
the extent and predictors of ART non-adherence. 
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The remaining studies in this section addressed cost-
effective and economic aspects of treatment (6,19) and 
self-medication practices among university students 
(9).  
 
1. Aantjes CJ, Quinlan TKC, Bunders JFG. Chronic 
care in Africa: how the experience with expanding 
antiretroviral treatment programmes for HIV can 
serve patients with other chronic conditions. Paper 
presented at the 21st International AIDS 
Conference; Durban, South Africa; 2016, Abstract 
no. WEPEE527. 
2. Adere AB. Quality of sexually transmitted 
infections (STIs) case management was found 
poor in health care facilities of Adama Town, 
eastern Ethiopia 2015; the missed opportunity to 
control HIV epidemic. Paper presented at the 52nd 
Annual Medical Conference of the Ethiopian 
Medical Association; Addis Ababa; 2016, Abstract 
no. AB-002. 
3. Admassu Z. Factor influencing sputum smear 
conversion at the end of two months of 
tuberculosis treatment among new smear positive 
pulmonary tuberculosis patients in an Addis Ababa 
public health center. Paper presented at the 
American Public Health Association's 2016 
Annual Meeting and Expo; Denver, CO, USA; 
2016, Abstract no. Board 2. 
4. Alemayehu M, Wubshet M, Mesfin N. Magnitude 
of visceral leishmaniasis and poor treatment 
outcome among HIV patients: meta-analysis and 
systematic review. HIV AIDS 2016;8:75-81. 
5. Ali SA, Mavundla TR, Fantu R, Awoke T. 
Outcomes of TB treatment in HIV co-infected TB 
patients in Ethiopia: a cross-sectional analytic 
study. BMC Infect Dis 2016;16(1):640. 
6. Amogne W. Investigating cost-effective strategies 
towards chronic hepatitis B treatment in Ethiopia. 
Paper presented at the 52nd Annual Medical 
Conference of the Ethiopian Medical Association; 
Addis Ababa; 2016, Abstract no. AB-57. 
7. Anlay DZ, Alemayehu ZA, Dachew BA. Rate of 
initial highly active anti-retroviral therapy regimen 
change and its predictors among adult HIV 
patients at University of Gondar Referral Hospital, 
northwest Ethiopia: a retrospective follow up 
study. AIDS Res Ther 2016;13:10. 
8. Arage G, Assefa G, Kassa H. Adherence to 
antiretroviral therapy and its associated factors 
among children at South Wollo Zone Hospital, 
northeast Ethiopia: a cross-sectional study. Paper 
presented at the 27th Annual Conference of the 
Ethiopian Public Health Association; Addis 
Ababa; 2016, Abstract no. Poster 15. 
9. Argaw MD, Bekele S, Yalew A. Magnitude and 
factors associated with self-medication practices 
among university students: the case of Arsi 
University, College of Health Science, Asella, 
Ethiopia. Paper presented at the American Public 
Health Association's 2016 Annual Meeting and 
Expo; Denver, CO, USA; 2016, Abstract no. 
Board 4. 
10. Aschalew J. Comparative study on changes in 
hematological parameters during the first six 
months of ART initiation among HIV infected 
pregnant and non-pregnant women at Zewditu 
Memorial Hospital, Addis Ababa, Ethiopia. 
Thesis, Addis Ababa University; 2016. 
11. Asefa W, Tsegaye D, Dalebout S, Ahmed E. 
Improving adherence to antiretroviral therapy in 
Namibia. Health Aff (Millwood) 
2016;35(12):2348. 
12. Asres A, Deressa W, Jerene D. Treatment 
outcomes of six and eight months tuberculosis 
treatment regimens in districts of southwestern 
Ethiopia. Paper presented at the 27th Annual 
Conference of the Ethiopian Public Health 
Association; Addis Ababa; 2016, Abstract no. 
Poster 41. 
13. Asres A, Jerene D, Deressa W. Tuberculosis 
treatment outcomes of six and eight month 
treatment regimens in districts of southwestern 
Ethiopia: a comparative cross-sectional study. 
BMC Infect Dis 2016;16(1):653. 
14. Ayalew MB, Kumilachew D, Belay A, Getu S, 
Teju D, et al. First-line antiretroviral treatment 
failure and associated factors in HIV patients at the 
university of Gondar Teaching Hospital, Gondar, 
northwest Ethiopia. HIV/AIDS - Research and 
Palliative Care 2016;8:141-146. 
15. Ayele HT, Mourik MSV, Bonten M. Predictors of 
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Section 6: Health Services and Health Policy 
Research 
This section includes reports on research and 
programmatic activities that aimed at expanding and 
improving the healthcare system including such issues 
as expansion of services for people living with 
HIV/AIDS, health resource economics and 
management, healthcare staff training, and national as 
well as international policies, laws, and guidelines for 
the provision of services and the protection of people 
living with HIV/AIDS, women, children, and other 
vulnerable groups. 
 
This section is comprised of 43 journal articles, 24 
conference presentations, one masters thesis, and one 
newswire article that deal with a range of issues related 
to health services and health policy across broad sub-
categories of (1-69): from service quality, access, 
utilization, and client satisfaction; HIV/AIDS and 
family planning; infection prevention including needle 
prick and transfusion related transmissions; training 
and capacity building including diagnostic 
developments; to cost, financing and policy related 
issues. 
 
Clinical as well as laboratory quality were issues dealt 
with majority of the articles (10, 19, 25, 27, 28, 30, 34, 
35, 39, 43, 44, 49, 57, 58, 66).  Regarding service 
quality Burusie (19) found the quality of case 
management for sexually transmitted infection in 
facilities in Adama town to be poor, while Getnet et al. 
(25) presented a systematic review and meta-analysis 
(in which a number of studies were from Ethiopia) 
related to delays in diagnosis of pulmonary 
tuberculosis in low and middle-income country 
settings. According to Tadesse et al. (58), concerns 
about covert HIV testing are associated with delayed 
presentation of adults with suspected malaria cases. 
The study by Gizaw et al. (27) showed that one third of 
the health workers in public facilities in Addis Ababa 
had relatively poor knowledge and nearly half of them 
had unsatisfactory practice on tuberculosis infection 
control. Through the evaluation of Ethiopia’s health 
extension program, Haregreaves et al. (28) presented 
the key aspects of measuring implementation strength 
methodology to be used in evaluating public health 
strategies in low and middle-income settings; while 
Johnson et al. (30) looked at the accuracy of eligibility 
for early medical abortion by community health 
workers using a simple checklist tool in Ethiopia India, 
and South Sudan. Tadele and Lamaro (57), in a 
community based study, assessed antenatal care service 
utilization and associated factors in southern Ethiopia; 
while Yakob and Ncama (66) investigated factors 
associated with perceived access to HIV/AIDS 
Treatment and care services in Wolaita Zone, Ethiopia. 
Pertaining to laboratory service quality, Asrat (10) and 
Mosissa et al. (43) assessed the performance of 
tuberculosis smear microscopists on external quality 
assessment, and Mossie et al. (44) assessed the 
knowledge, attitudes and practice of tuberculosis 
infection control among medical laboratory 
professionals in selected health facilities in Addis 
Ababa. Kebede A, et al. (34) stressed the importance of 
accreditation in point-of-care testing for quality control 
outside the laboratory environment, while Kebede Y, et 
al. (35) highlighted the feasibility of public-private 
partnership in improving specimen referrals and 
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improving quality of laboratory services. 
Ndihokubwayo et al. (49) present the preliminary 
results of WHO-AFRO’s Stepwise Laboratory 
(Quality) Improvement Process towards Accreditation 
(SLIPTA) process in which nine public laboratories 
from Ethiopia were included. 
 
The themes of the next group of articles (8, 12, 24, 32, 
41, 47, 52, 59, 67, 68) included training, capacity 
building including developments in diagnostic 
capacity. Alemu and Alemayehu (8) presented on 
partnering to fill biomedical engineer and technician 
human resource gaps in Ethiopia, while Bacha et al. 
(12) presented on initiatives to improve emergency and 
critical care services for pediatric HIV patients. 
Getachew and Haile (24) explored continuing 
professional development needs of general medical 
practitioners; while, using task analysis, Yigzaw et al. 
(68) generated evidence for strengthening midwifery 
education, practice, and regulation. Kalibala et al. (32) 
reported the experiences in implementation and 
publication of operations research interventions. The 
presentation by Mizwa et al. (41) dealt with 
longitudinal north-south partnership in pediatrics to 
improve HIV/AIDS care and treatment, while 
Mumford et al. (47) discussed the progress in 
international twinning partnership between European 
palliative care centers and a non-governmental hospice 
in Ethiopia. In terms of investments in diagnostic 
capacity, Tadesse (59) presented an assessment of 
diagnosis and treatment facilities for cervical cancer in 
public health institutions in Addis Ababa; while Price 
and Asgary (52) described the implementation and 
feasibility of an adapted two-stage visual inspection 
with acetic acid/cryotherapy-based cervical cancer 
screening program for HIV-infected women in the 
same city. Similarly, Yebyo et al. (67) explored the 
pattern of C-reactive protein point-of-care testing and 
antibiotic prescribing for acute respiratory tract 
infections in rural primary health centers of north 
Ethiopia. 
 
Another group of articles (13-15, 26, 31, 37, 45, 60, 
63) raised issues of patterns of service utilization 
including access and delivery arrangements. Bane et al. 
(13) retrospectively studied medical admissions and 
outcomes at Saint Paul’s Hospital in Addis Ababa, 
Ethiopia; Belayihun et al. (15) presented trends in 
antenatal care attendance and their link to skill delivery 
services; Girmye and Berhan (26) presented on skilled 
antenatal care service utilization and its association 
with the characteristics of women's health development 
team in southwest Ethiopia; while Bayu et al. (14) 
looked at cervical cancer screening service uptake and 
associated factors among age eligible women in 
Mekelle Zone. Kaba et al. (31) qualitatively explored 
why women in urban settings fail to use available 
maternal health services; and King et al. (37) similarly 
looked at the utilization of maternal health services in 
Ethiopia. Motuma et al. (45) presented on the 
utilization of youth friendly services and associated 
factors among youth in east Ethiopia; while Tekleab et 
al. (60) looked at antenatal care and women's decision-
making power as determinants of institutional delivery 
in a rural area. According to Workalemahu et al. (63), 
drop-in centers drive higher yield and better linkage to 
treatment for female sex workers. 
 
There were a group of articles (21, 22, 29, 46, 53, 69) 
that dealt with cost, financing, and investment needs, as 
well as a couple (36, 54, 56) related to policy and 
framework issues. De Cuevas et al. (21) estimated 
patient side direct costs for tuberculosis diagnosis, and 
Fieno et al. (22) made a political economy analysis of 
human resources for health in Africa; while Hontelez et 
al. (29) discussed the investment needs and cost-
effectiveness within changing HIV treatment eligibility 
under health system constraints in sub-Saharan Africa. 
Remme et al. (53) discussed the issue of financing the 
HIV response in sub-Saharan Africa from domestic 
sources; while Moucheraud et al. (46) claimed that 
PEPFAR investments in governance and health 
systems were one-fifth of countries' budgeted funds 
during 2004-2014. Furthermore, Zegeye et al. (69) 
conducted a cost-analysis of the prevention of mother 
to child transmission of HIV/AIDS services in 
Ethiopia. Kesetebirhan et al. (36) indicated a lesson on 
pro–poor pathway towards universal health coverage; 
Seyoum et al. (54) discussed the role of community 
knowledge and those of health extension workers on 
integrated diseases among households; and Shiferaw et 
al. (56) dealt with the policy, regulation and strategies 
for control and elimination viral hepatitis. 
 
Six articles (4, 7, 17, 33, 42, 65) in this category dealt 
with issues of infection prevention including 
prevention of needle prick and transfusion related 
transmissions. Abraham (4), Kaweti & Abegez (33), as 
well as Worku et al. (65) presented on the prevalence 
of and response to needle stick injuries, including 
exposure to blood and blood fluids among health 
workers in hospitals in Addis Ababa and Hawassa. 
Alemayehu et al. (7) explored sharps injury and 
exposure to blood and body fluids among health care 
workers in health care centers of eastern Ethiopia; 
while Bisetegne et al. (17) as well as Mohammed and 
Bekele (42) looked at transfusion-transmissible 
infections among blood donors in different parts of 
Ethiopia. 
 
HIV/AIDS and family planning and related issues were 
raised by five articles (2, 5, 61, 62, 64).   Abeje and 
Motbaynor (2) explored the demand for family 
planning among HIV- positive women on anti-
retroviral treatment in South Gondar and North Wollo 
Zones of Amhara Region.  Adamchak et al. (5) 
presented results from a pilot test that developed 
indicators to monitor family planning and HIV service 
integration. Thomas et al. (61) discussed improving 
referrals and integrating family planning and HIV 
services through organizational network strengthening; 
while Wendwossen and Nigatu (62) delt with 
partnering to strengthen obstetrics and gynecology 
training as a way to prevent new HIV infections, and 
Worke et al. (64) studied the utilization of 
contraception among sexually active HIV- positive 
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women attending ART clinic in University of Gondar 
Hospital. 
 
More than a couple of articles in this category (1, 3, 23, 
51) have dealt with issues related to client satisfaction 
in the delivery of care. Abebe et al. (1) found overall 
low level of satisfaction among respondents with 
pharmaceutical services provided at Gondar University 
Hospital; Aberra et al. (3) present early experiences 
from a pilot program for treatment of chronic hepatitis 
B in Ethiopia; Getachew described patients' satisfaction 
and associated factors towards health services in the 
adult emergency department of Tikur Anbsssa 
Hospital, while Obsa and Worji (51) describe factors 
associated to satisfaction with outpatient services at 
Assela Teaching Referral Hospital in Arsi Region. 
 
Patterns of drug supply including adverse reactions 
were dealt with by three articles (11, 16, 20) in this 
category. Ayisa et al. (11) presented on knowledge, 
practice and associated factors towards adverse drug 
reaction reporting among nurses working in district 
hospitals in northwest Ethiopia; Berhanemeskel et al. 
(16) described HIV/AIDS related commodities supply 
chain management in public health facilities of Addis 
Ababa; and Dayo et al. (20) explored the pattern of 
student interventions on international pharmacy 
rotation. 
 
Aklilu et al. (6) assessed knowledge and perception of 
health professionals towards toxoplasmosis in selected 
towns; an anonymous poster presentation (9) on 
bridging to a sustainable future in global health was 
made at the 7th Conference of Consortium of 
Universities for Global Health; and according to Burki 
(18), Ethiopia is considered as showing that it is single-
minded in tackling diseases. Kitaw (38) outlined 
lessons for the future in the health sector in Ethiopia. 
Mall et al. (40) reported on a qualitative study to 
inform development of care for people with severe 
mental disorders in rural Ethiopia. 
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Section 7: Health Informatics, Monitoring and 
Evaluation 
This section deals with the use of modeling and 
prediction, quantitative assessment, analytic and 
communication methods and research concerning 
monitoring and evaluation of HIV/AIDS programs. It 
covers the systematic application of information, 
computer science, and technology for HIV/AIDS 
prevention, care, research and evaluation. 
 
There are 17 articles and reports in this section. The 
first report by Adepoju revealed a drone delivery 
system to get the desperately needed blood and medical 
supplies to outlying hospitals and doctors in Rwanda 
that had been developed by the San Franciso based tech 
start-up Zipline which was found very successful and 
can be scaled-up to neighboring African countries. 
 
On the other hand, Statistical modeling of ART 
outcomes by Awoke et al, Dali et al, Hissaini et al and 
Sibhatu MK have also show different levels of 
improvement in the treatment outcomes of HIV/AIDS 
patients. The study by Dali and colleagues, for 
instance, informed the direction of research capacity 
and best practices for HIV testing strategies for 
population-based interventions in sub-Saharan Africa 
in addition to the understanding of what factors can 
influence rates of testing that could prove critical to 
improving testing, treatment and prevention processes. 
Hissaini and colleagues have also developed and used a 
model for the transmission dynamics of anthroponotic 
visceral leishmaniasis (AVL) and human 
immunodeficiency virus (HIV) in a population to 
assess the impact of the spread of each disease on the 
overall transmission dynamics. 
 
Moreover, Fetene employed data mining technique for 
measuring the prognosis of HIV/AIDS whereas Inzaule 
and colleagues indicated an affordable HIV drug-
resistance testing for monitoring of antiretroviral 
therapy in Sub-Saharan Africa. Besides, seminal works 
by Gebriel et al, Letebo and Shiferaw, Menberu, Olana 
et al, Ondoa et al, Tesfaye et al and Woldeamanuel et 
al showed validated and adapted data collection tools 
and diagnosis procedures which were found effective 
in a low income setting. Gebriel and colleagues 
demonstrated the reliability and validity of an 
interviewer-administered adaption of the youth self-
report for mental health screening of vulnerable young 
people in Ethiopia.  Letebo and Shiferaw adapted HIV 
patient and program monitoring tools for chronic non-
communicable diseases in Ethiopia, while Menberu 
assessed the performance of the WHO 2011 TB 
symptom screening algorithm for pulmonary TB 
diagnosis among HIV-infected patients. Tesfaye and 
colleagues adapted and validated the short version 
WHOQOL-HIV in Ethiopia while Woldeamanuel and 
his colleagues developed, validated and field tested an 
instrument for clinical assessment of HIV-associated 
neuropathy and neuropathic pain in resource-restricted 
and large population study settings.   On the other 
hand, Olana and colleagues have shown an early infant 
HIV diagnosis procedure using DNA-PCR using an 
eight years data. A new matrix for scoring the 
functionality of national laboratory networks in Africa 
by introducing the Labnet Scorecard was developed by 
Ondoa and colleagues. 
 
In addition, two articles focused the economic 
implication of the HIV/AIDS pandemic.  Hernandez-
Villafuerte and colleagues documented the bibliometric 
trends of health economic evaluation in Sub-Saharan 
Africa while, Zegeye and colleagues showed the 
economic costs of patients attending the prevention of 
mother -to- child transmission of HIV/AIDS (PMTCT) 
services in Ethiopia in both an urban and rural settings. 
A web-based TB patient follow-up information system 
has been designed by Shekur. 
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Section 8: Diaspora Research 
This section includes studies on HIV/AIDS among 
Ethiopians in the Diaspora and of Ethiopian health 
professionals in the Diaspora contributing to 
HIV/AIDS interventions in Ethiopia. 
 
We found only two published studies on HIV among 
Ethiopians in the diaspora. In the first study, Daw et al. 
analyzed the prevalence of HIV and HIV-HCV co-
infection in serum samples collected among 14,205 
immigrants from North and Sub-Saharan Africa. 
Overall, 309 (2.3%) individuals were found to be 
positive for HIV and 109 (0.8%) for HIV/HCV 
coinfection. Immigrants from Burkina Faso/Ivory 
Coast (7.8%), Nigeria/Ghana (6%), and Ethiopia 
(5.2%) had the top three highest levels of HIV 
infection. Among Ethiopian immigrants with HIV, 
29.7% had HCV co-infection, which was lower than 
the average 35.3% for all immigrants combined. Van 
Kesteren and Wojciechowski (2) conducted a 
retrospective analysis of the medical records of 315 
adopted Ethiopian children in Belgium. The results 
indicate high prevalence of stunting and intestinal 
parasites but none of the children tested positive for 
HIV, syphilis or hepatitis C. 
 
1. Daw MA, El-Bouzedi A, Ahmed MO, Dau AA, 
Agnan MM, et al. Prevalence of human immune 
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from north and Sub-Saharan Africa. Travel Med 
Infect Dis 2016;14(6):637-638. 
2. Van Kesteren L, Wojciechowski M. International 
adoption from Ethiopia: an overview of the health 
status at arrival in Belgium. Acta Clin Belg 
2017;72(5):300-305. 
 
Section 9: Previous bibliographies 
This section lists the previous year’s update and 
potentially other bibliographies that were published 
during 2016. Another 13 bibliographies were published 
between 2003 and 2015 in this journal. 
 
Converse, PJ, Haile Mariam D, Kloos H, Mekonnen 
W, Mulatu MS, Kaba M. Bibliography on HIV/AIDS 
in Ethiopia and Ethiopians in the Diaspora: The 2015 
Update. Ethiop J Health Dev 2016; 30(3): 103-276. 
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Section 10: Selected Websites Featuring HIV/AIDS 
in Ethiopia 
1. Federal HIV/AIDS Prevention and Control Office 
of Ethiopia: http://www.hapco.gov.et 
2. Ethiopian Public Health Association: 
http://www.etpha.org/ 
3. Ethiopian AIDS Resources Center: 
http://www.etharc.org 
4. Family Health International: 
http://www.fhi360.org/countries/ethiopia 
5. Christian Relief and Development Association: 
www.crdaethiopia.org 
6. People to People Organization: 
http://www.peoplepeople.org 




8. United Nations Children's Fund (UNICEF): 
http://www.unicef.org/ethiopia/HIV_AIDS_464.ht
ml 
9. United Nations Joint Program on AIDS 
(UNAIDS):http://www.unaids.org/en/Regionscoun
tries/Countries/Ethiopia 
10. United States Agency for International 
Development: http://www.usaid.gov/ethiopia/ 
global-health 




12. University of California, San Francisco HIV In 
Site: http://hivinsite.ucsf.edu/global?page=cr09-et-
00 
13. The International Technical Training and 
Education Center on HIV (I-TECH) of the 
University of Washington: 
https://www.go2itech.org/?s=ethiopia 
14. The International Center for AIDS Care and 
Treatment Programs (ICAP) at Columbia 
15. University’s Mailman School of Public Health: 
http://icap.columbia.edu/where-we-work/ethiopia 
16. World Health Organization: 
http://www.who.int/countries/eth/en/  
17. Management Sciences for Health’s Ethiopia 
Network for HIV/AIDS Treatment, Care and 
Support (ENHAT-CS) Project 
http://www.msh.org/our-work/projects/ethiopia-
network-for-HIV-AIDS-treatment-care-support 
18. The Twinning Center: 
http://www.twinningagainstaids.org/ethiopia.html
